Concepedia

Mark Bruce

MB

6

Publications

156

Citations

6

H-Index

1987

Active since

Affiliations

Ono Pharmaceutical (United Kingdom)(Current)

Ono Pharmaceutical (Japan)

Mark Bruce is an author at Ono Pharmaceutical (United Kingdom) specializing in diabetes, physiology, and nutrition.

ORCID

Top concepts

Publications per year

1987–2021

6

Publications

6

Glutamine supplementation promotes anaplerosis but not oxidative energy delivery in human skeletal muscle

Mark Bruce, Dumitru Constantin‐Teodosiu, Paul L. Greenhaff et al. · American Journal of Physiology-Endocrinology and Metabolism · 2001 · 53 citations

ONO‐7684 a novel oral FXIa inhibitor: Safety, tolerability, pharmacokinetics and pharmacodynamics in a first‐in‐human study

Dominic Beale, Jeremy Dennison, Malcolm Boyce et al. · British Journal of Clinical Pharmacology · 2021 · 39 citations · Full text

Oral glucose tolerance and ambient temperature in non-diabetic subjects

Abayomi O. Akanji, Mark Bruce, Keith N. Frayn et al. · Diabetologia · 1987 · 23 citations · Full text

, , +4

Randomised clinical trial: exploratory phase 2 study of <scp>ONO</scp> ‐2952 in diarrhoea‐predominant irritable bowel syndrome

William E. Whitehead, Kevin J. Duffy, John Sharpe et al. · Alimentary Pharmacology & Therapeutics · 2016 · 19 citations · Full text

Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys

Hiroyuki Yamada, Yasuo OCHI, Hiroshi Mori et al. · Bone · 2016 · 12 citations

, , +12

Rows per page

1–5 of 6